References

Nonadjuvanted bivalent respiratory syncytial virus vaccination and perinatal outcomes

10.1001/jamanetworkopen.2024.19268 · ExternalCitation · doi-reference

Respiratory syncytial virus vaccine and nirsevimab uptake among pregnant people and their neonates

10.1001/jamanetworkopen.2024.60735 · ExternalCitation · doi-reference

Maternal respiratory syncytial virus prefusion F vaccination and acute respiratory illness in infants

10.1001/jamanetworkopen.2026.16773 · ExternalCitation · doi-reference

Sequential safety surveillance of RSVpreF vaccination during pregnancy early in the postapproval period

10.1001/jamanetworkopen.2026.6190 · ExternalCitation · doi-reference

Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes

10.1002/14651858.cd015134.pub2 · ExternalCitation · doi-reference

Efficacy and safety of respiratory syncytial virus vaccines

10.1002/14651858.cd016131 · ExternalCitation · doi-reference

Maternal RSV vaccination for infant protection: a systematic review and meta-analysis of phase 3 trials with an integrated economic evaluation

10.1002/ijgo.70641 · ExternalCitation · doi-reference

Maternal RSV vaccine: a systematic review and meta-analysis of immunogenicity and perinatal safety

10.1007/s12026-025-09732-4 · ExternalCitation · doi-reference

Secretory IgA: linking microbes, maternal health, and infant health through human milk

10.1016/j.chom.2022.02.005 · ExternalCitation · doi-reference

Impact and effectiveness of RSV maternal immunization on infant hospitalizations in Buenos Aires: a hospital-based, multicentre, retrospective surveillance cohort study

10.1016/j.lana.2025.101316 · ExternalCitation · doi-reference

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

10.1016/s0140-6736(22)00478-0 · ExternalCitation · doi-reference

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

10.1016/s0264-410x(03)00352-9 · ExternalCitation · doi-reference

Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case-control study

10.1016/s1473-3099(25)00156-2 · ExternalCitation · doi-reference

Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysis

10.1016/s1473-3099(25)00624-3 · ExternalCitation · doi-reference

Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study

10.1016/s2352-4642(25)00155-5 · ExternalCitation · doi-reference

A national programme of bivalent prefusion F vaccination in pregnancy and protection against respiratory syncytial virus hospitalisation in infants until age 6 months in the UK: a multicentre, prospective, test-negative, case-control study

10.1016/s2352-4642(26)00134-3 · ExternalCitation · doi-reference

The impact of maternal respiratory syncytial virus vaccination on infant and perinatal outcomes: a systematic review and meta-analysis of randomized controlled trials

10.1038/s41372-026-02675-0 · ExternalCitation · doi-reference

Maternal safety outcomes of respiratory syncytial vaccination during pregnancy with a large-scale database

10.1038/s41541-026-01373-4 · ExternalCitation · doi-reference

Respiratory syncytial virus vaccination during pregnancy and effects in infants

10.1056/nejmoa1908380 · ExternalCitation · doi-reference

Prefusion F protein-based respiratory syncytial virus immunization in pregnancy

10.1056/nejmoa2106062 · ExternalCitation · doi-reference

Bivalent prefusion F vaccine in pregnancy to prevent respiratory syncytial virus illness in infants

10.1056/nejmoa2216480 · ExternalCitation · doi-reference

RSV prefusion F protein-based maternal vaccine - preterm birth and other outcomes

10.1056/nejmoa2305478 · ExternalCitation · doi-reference

Randomized, placebo-controlled phase 3 trial evaluating safety, immunogenicity, and reactogenicity of RSVPreF3-mat in high-risk pregnant women and their infants

10.1080/21645515.2026.2613565 · ExternalCitation · doi-reference

RSV prophylactics for pediatric populations: a product review and meta-analysis of real-world effectiveness

10.1080/21645515.2026.2690750 · ExternalCitation · doi-reference

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

10.1093/ije/dyi274 · ExternalCitation · doi-reference

Safety and immunogenicity of an investigational respiratory syncytial virus vaccine (RSVPreF3) in mothers and their infants: a phase 2 randomized trial

10.1093/infdis/jiad024 · ExternalCitation · doi-reference

Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants

10.1093/infdis/jiz390 · ExternalCitation · doi-reference

Efficacy, safety, and immunogenicity of the MATISSE (maternal immunization study for safety and efficacy) maternal respiratory syncytial virus prefusion F protein vaccine trial

10.1097/aog.0000000000005816 · ExternalCitation · doi-reference

Maternal and neonatal outcomes after respiratory syncytial virus prefusion F protein vaccination during pregnancy: analysis from the 2024–2025 immunization campaign in France

10.1097/aog.0000000000006121 · ExternalCitation · doi-reference

Maternal respiratory syncytial virus vaccination and preterm birth: a Utah statewide retrospective cohort study

10.1097/aog.0000000000006130 · ExternalCitation · doi-reference

Maternal immunization with RSVpreF vaccine: effectiveness in preventing respiratory syncytial virus-associated hospitalizations in infants under 6 months in Argentina: multicenter case-control study

10.1097/inf.0000000000004878 · ExternalCitation · doi-reference

Respiratory syncytial virus vaccination is associated with increased odds of preterm birth - a rapid review and meta-analysis

10.1111/apa.17595 · ExternalCitation · doi-reference

Perinatal outcomes and uptake of RSV vaccine during pregnancy in South London: a cross-sectional study

10.1136/bmjopen-2025-101592 · ExternalCitation · doi-reference

Real-world effectiveness and safety of nirsevimab, RSV maternal vaccine and RSV vaccines for older adults: a living systematic review and meta-analysis

10.1136/thorax-2025-223376 · ExternalCitation · doi-reference

Respiratory syncytial virus maternal vaccination in infants below 6 months of age: meta-analysis of safety, immunogenicity, and efficacy

10.1159/000536031 · ExternalCitation · doi-reference

Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review

10.1186/s12879-015-1154-y · ExternalCitation · doi-reference

Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of RSV-associated lower respiratory tract disease in infants: recommendations of the advisory committee on immunization practices - United States, 2023

10.15585/mmwr.mm7241e1 · ExternalCitation · doi-reference

Safety, tolerability, and immunogenicity of RSVpreF vaccine in pregnant individuals living with HIV

10.3390/vaccines13121218 · ExternalCitation · doi-reference

The impact of IgG transplacental transfer on early life immunity

10.4049/immunohorizons.1700057 · ExternalCitation · doi-reference